HDAC inhibitor sodium butyrate prevents allergic rhinitis and alters lncRNA and mRNA expression profiles in the nasal mucosa of mice

Our previous study demonstrated that intranasal administration of histone deacetylase inhibitor sodium butyrate (NaB) exhibits therapeutic effects on a mouse model of allergic rhinitis (AR). However, whether NaB is effective on AR when administered orally and prophylactically, as well as its potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jie, Cui, Mu, Sun, Fei, Zhou, Ke, Fan, Bei, Qiu, Jian-Hua, Chen, Fu-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053856/
https://www.ncbi.nlm.nih.gov/pubmed/32124940
http://dx.doi.org/10.3892/ijmm.2020.4489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053856/
https://www.ncbi.nlm.nih.gov/pubmed/32124940
http://dx.doi.org/10.3892/ijmm.2020.4489

Ejemplares similares